Yatin Sanue
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Yatin Sanue
Yatin Sanue is recorded as Analyst at Guggenheim. Yatin Sanue has spoken on 1 investor event across 1 company, most recently for Zenas BioPharma, Inc. on September 29, 2026. The companies whose calls Yatin Sanue spoke on are classified in the Healthcare sector.
Yatin Sanue on recent calls
“I had a few for Dr. Katz as well, please. So the first one is, as you noted, the very severe patients are the small minority of the population.”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current